Commentary: Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy

Detalles Bibliográficos
Autores principales: Durán, Javier, Estrada, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917040/
https://www.ncbi.nlm.nih.gov/pubmed/29726548
http://dx.doi.org/10.3389/fphar.2018.00381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917040/
https://www.ncbi.nlm.nih.gov/pubmed/29726548
http://dx.doi.org/10.3389/fphar.2018.00381

Ejemplares similares